Isispharma Neotone Sensitive Balm 30ml
₦44,906.00
Sensitive Balm by Isispharma – Essential for dull skin routines. High-quality, effective, and reliable.
What is Isispharma Neotone Sensitive Balm used for?
This intensive balm from the Neotone range corrects pigmentation spots.
This Isispharma product is a night cream that significantly reduces pigmentation spots on the sensitive face and hands, thanks to the patented DEPI-ACT complex. This patent contains a combination of carefully selected active ingredients with moisturizing and depigmenting properties.
- This anti-dark spot sun protection contains diacetyl boldine, which promotes skin lightening on a daily basis.
- This fluid contains a pure licorice extract derived from licorice root, with strong depigmenting properties.
- This cosmetic contains niacinamide, a B3 vitamin that reduces blemishes and brightens the complexion.
Neotone Sensitive contains a combination of squalane + glycerine + shea butter of natural origin. These active ingredients strengthen the skin barrier. This skin care product also contains brown algae from Brittany, which helps reduce melasma or “pregnancy mask”.
Isispharma Neotone Sensitive Balm is specially formulated to care for sensitive skin prone to pigmentation spots. Its gentle, soothing formula works deep down to reduce dark spots while leaving your skin feeling comfortable.
Enriched with shea butter, glycerine and squalane, this balm provides intensive hydration and nutrition for your skin, leaving it soft and supple. It also creates a protective barrier that helps strengthen the skin’s barrier and shield your skin from external aggressors.
Niacinamide, the balm’s star ingredient, works in synergy with licorice extract to visibly reduce pigmentation spots, even out skin tone and reveal more radiant, luminous skin.
Its light, non-greasy texture enables the balm to penetrate your skin quickly without leaving any unpleasant residue. Apply in the morning or evening, massaging gently for optimum absorption.
Reviews
There are no reviews yet.